• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐碳青霉烯鲍曼不动杆菌:耐药机制的多样性和感染的危险因素。

Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.

机构信息

Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

Epidemiol Infect. 2012 Jan;140(1):137-45. doi: 10.1017/S0950268811000744. Epub 2011 Apr 18.

DOI:10.1017/S0950268811000744
PMID:21554783
Abstract

Carbapenem-resistant Acinetobacter baumannii (CRAB) are an increasing infectious threat in hospitals. We investigated the clinical epidemiology of CRAB infections vs. colonization in patients, and examined the mechanisms of resistance associated with elevated minimum inhibitory concentrations (MICs) for carbapenems. From January to June 2009, 75 CRAB strains were collected. CRAB infection was significantly associated with malignancy and a high APACHE II score. The most dominant resistance mechanism was ISAba1 preceding OXA-51, producing strains with overexpression of efflux pump. Strains carrying blaOXA-23-like enzymes had higher carbapenem MICs than those carrying blaOXA-51-like enzymes; however, the presence of multiple mechanisms did not result in increased resistance to carbapenems. There was no difference in the resistance mechanisms in strains from infected and colonized patients. The majority of strains were genetically diverse by DNA macrorestriction although there was evidence of clonal spread of four clusters of strains in patients.

摘要

鲍曼不动杆菌碳青霉烯耐药株(CRAB)是医院中日益严重的感染威胁。我们调查了患者中 CRAB 感染与定植的临床流行病学,并研究了与碳青霉烯最低抑菌浓度(MIC)升高相关的耐药机制。2009 年 1 月至 6 月,共收集了 75 株 CRAB 菌株。CRAB 感染与恶性肿瘤和高急性生理与慢性健康评分(APACHE II)显著相关。最主要的耐药机制是 ISAba1 位于 OXA-51 之前,导致外排泵过度表达。携带 blaOXA-23 样酶的菌株对碳青霉烯类的 MIC 值高于携带 blaOXA-51 样酶的菌株;然而,多种机制的存在并未导致对碳青霉烯类的耐药性增加。感染和定植患者的菌株耐药机制无差异。尽管有证据表明患者中有四个菌株簇的克隆传播,但大多数菌株的 DNA 宏限制图谱具有遗传多样性。

相似文献

1
Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.耐碳青霉烯鲍曼不动杆菌:耐药机制的多样性和感染的危险因素。
Epidemiol Infect. 2012 Jan;140(1):137-45. doi: 10.1017/S0950268811000744. Epub 2011 Apr 18.
2
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.在捷克共和国,鲍曼不动杆菌对碳青霉烯类抗生素耐药性的出现与欧洲克隆II型多重耐药菌株的传播有关。
J Antimicrob Chemother. 2008 Sep;62(3):484-9. doi: 10.1093/jac/dkn205. Epub 2008 May 13.
3
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.韩国除鲍曼不动杆菌外的碳青霉烯类耐药不动杆菌的特性。
Int J Antimicrob Agents. 2012 Jan;39(1):81-5. doi: 10.1016/j.ijantimicag.2011.08.006. Epub 2011 Oct 12.
4
Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.Tn2006 在台湾耐碳青霉烯鲍曼不动杆菌临床分离株中 AbaR4 型耐药岛上的广泛传播。
Int J Antimicrob Agents. 2012 Aug;40(2):163-7. doi: 10.1016/j.ijantimicag.2012.04.018. Epub 2012 Jun 27.
5
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.意大利碳青霉烯类耐药鲍曼不动杆菌临床分离株的流行病学特征和分布。
Clin Microbiol Infect. 2012 Feb;18(2):160-6. doi: 10.1111/j.1469-0691.2011.03527.x. Epub 2011 Jul 1.
6
Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey.土耳其产 OXA-58 碳青霉烯类耐药鲍曼不动杆菌暴发菌株的特征。
Int J Antimicrob Agents. 2010 Aug;36(2):114-8. doi: 10.1016/j.ijantimicag.2010.03.017. Epub 2010 May 26.
7
Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital.耐碳青霉烯类、产OXA-23型酶的鲍曼不动杆菌在保加利亚一家大学医院的克隆传播
Clin Microbiol Infect. 2008 Jul;14(7):723-7. doi: 10.1111/j.1469-0691.2008.02018.x.
8
Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.加拿大耐多药及耐碳青霉烯类鲍曼不动杆菌的鉴定:2007年加拿大抗菌药物耐药监测(CANWARD)结果
J Antimicrob Chemother. 2009 Sep;64(3):552-5. doi: 10.1093/jac/dkp225. Epub 2009 Jul 3.
9
Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan.巴基斯坦卡拉奇市公立和私立医疗机构重症监护病房中耐碳青霉烯类鲍曼不动杆菌临床分离株的分子和流行病学特征。
J Hosp Infect. 2011 Jun;78(2):143-8. doi: 10.1016/j.jhin.2011.01.029. Epub 2011 Apr 2.
10
Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.巴西南部库里蒂巴地区碳青霉烯类耐药鲍曼不动杆菌的时间演变。
Am J Infect Control. 2010 May;38(4):308-14. doi: 10.1016/j.ajic.2009.09.012. Epub 2010 Jan 31.

引用本文的文献

1
Linarin and Hyperoside Inhibit lptD/msbA to Disrupt Membranes of Multidrug-Resistant .蒙花苷和金丝桃苷抑制lptD/msbA以破坏多重耐药菌的细胞膜
Biology (Basel). 2025 Aug 20;14(8):1087. doi: 10.3390/biology14081087.
2
Impact of the COVID-19 pandemic on the consumption of antibiotics and the emergence of AMR: case study in a general hospital.新冠疫情对抗生素使用及抗菌药物耐药性产生的影响:一家综合医院的案例研究
Front Public Health. 2025 Jun 23;13:1584574. doi: 10.3389/fpubh.2025.1584574. eCollection 2025.
3
Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.
鲍曼不动杆菌对碳青霉烯类耐药的地理分布及时间趋势:一项综合荟萃分析。
PLoS One. 2024 Dec 16;19(12):e0311124. doi: 10.1371/journal.pone.0311124. eCollection 2024.
4
Handwashing sinks as reservoirs of carbapenem-resistant in the intensive care unit: a prospective multicenter study.重症监护病房中作为碳青霉烯类耐药菌储库的手洗水槽:一项前瞻性多中心研究。
Front Public Health. 2024 Oct 9;12:1468521. doi: 10.3389/fpubh.2024.1468521. eCollection 2024.
5
Inside-out, antimicrobial resistance mediated by efflux pumps in clinical strains of Acinetobacter baumannii isolated from burn wound infections.从烧伤创面感染分离出的鲍曼不动杆菌临床菌株中,由外排泵介导的由内而外的耐药性。
Braz J Microbiol. 2024 Dec;55(4):3629-3641. doi: 10.1007/s42770-024-01461-4. Epub 2024 Jul 24.
6
Structural analysis of resistance-nodulation cell division transporters.耐药-结节细胞分裂转运蛋白的结构分析。
Microbiol Mol Biol Rev. 2024 Jun 27;88(2):e0019823. doi: 10.1128/mmbr.00198-23. Epub 2024 Mar 29.
7
Novel Antibacterial Agents 2022.新型抗菌药物 2022 年
Pharmaceuticals (Basel). 2024 Mar 13;17(3):370. doi: 10.3390/ph17030370.
8
ESKAPE in China: epidemiology and characteristics of antibiotic resistance.中国的 ESKAPE:耐药性的流行病学和特征。
Emerg Microbes Infect. 2024 Dec;13(1):2317915. doi: 10.1080/22221751.2024.2317915. Epub 2024 Feb 23.
9
CRISPR-Based Gene Editing in to Combat Antimicrobial Resistance.基于CRISPR的基因编辑用于对抗抗菌药物耐药性。
Pharmaceuticals (Basel). 2023 Jun 23;16(7):920. doi: 10.3390/ph16070920.
10
Enhanced activity of Ellagic acid in lipid nanoparticles (EA-liposomes) against in immunosuppressed mice.脂质纳米粒(鞣花酸脂质体,EA-脂质体)对免疫抑制小鼠的活性增强。
Saudi J Biol Sci. 2023 Aug;30(8):103707. doi: 10.1016/j.sjbs.2023.103707. Epub 2023 Jun 15.